login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
KORRO BIO INC (KRRO) Stock News
USA
- NASDAQ:KRRO -
US5009461089
-
Common Stock
6.26
USD
+0.04 (+0.64%)
Last: 11/19/2025, 2:57:52 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
KRRO Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Chartmill
- Mentions:
SRDX
CMCT
ASRT
OTLK
...
On Monday, there are stocks with unusual volume. Let's take a look.
6 days ago - By: Chartmill
- Mentions:
PETS
IDN
RUBI
KXIN
...
Keep an eye on the top gainers and losers in Thursday's session.
6 days ago - By: Benzinga
- Mentions:
ALKS
ENGN
IMMP
MLSS
...
12 Health Care Stocks Moving In Thursday's After-Market Session
6 days ago - By: Benzinga
- Mentions:
NVO
Korro Bio Early Trial Results Fall Short; Stock Hits New Low
6 days ago - By: Chartmill
- Mentions:
PETS
DDS
FLY
IDN
...
Which stocks are gapping on Thursday?
6 days ago - By: Investor's Business Daily
Korro Bio Plummets To A Record Low On A Big Setback In RNA-Editing
6 days ago - By: Chartmill
- Mentions:
SEE
FLY
RUBI
CMCT
...
Stay updated with the stocks that are on the move in today's pre-market session.
7 days ago - By: Stocktwits
Korro Bio Stock Crashes Over 75% After-Hours On Drug Failure, Downgrades And Layoffs — Yet Retail Flags ‘Buy-The-Fear’ Setup
7 days ago - By: Zacks Investment Research
- Mentions:
NTRB
Korro Bio, Inc. (KRRO) Reports Q3 Loss, Lags Revenue Estimates
3 months ago - By: Korro Bio, Inc.
Korro to Participate in Upcoming Investor and Scientific Conferences
3 months ago - By: Korro Bio, Inc.
Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates
4 months ago - By: Korro Bio, Inc.
Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110
7 months ago - By: Korro Bio, Inc.
Korro Reports First Quarter 2025 Financial Results and Provides Business Updates
8 months ago - By: Korro Bio, Inc.
Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer
8 months ago - By: Korro Bio, Inc.
Korro Reports Full Year 2024 Financial Results and Provides Business Updates
8 months ago - By: Korro Bio, Inc.
KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
9 months ago - By: Korro Bio, Inc.
Korro to Present at the TD Cowen 45th Annual Health Care Conference
11 months ago - By: Korro Bio, Inc.
Korro to Present at the 43rd Annual J.P. Morgan Healthcare Conference
a year ago - By: CAMP4 Therapeutics
- Mentions:
CAMP
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors
a year ago - By: Korro Bio, Inc.
Korro to Participate in Upcoming Investor Conferences
a year ago - By: Korro Bio, Inc.
Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency
Please enable JavaScript to continue using this application.